CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 645 enrolled
Drug / intervention
Tiotropium 2x2.5µg tiotropium (equivalent to 2x3.154µg tiotropium bromide monohydrate) Respimat® inhaler and cartridge Solution for inhalation +3 moredrug
Likely dose
Tiotropium 2x2.5µg tiotropium (equivalent to 2x3.154µg tiotropium bromide monohydrate) Respimat® inhaler and cartridge Solution for inhalationfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01937390
NCT01937390N/ACompleted
CompareCT.gov

Post-Marketing Observational Study of the Impact of Adherence to Treatment With Once-Daily Administered Long-Acting Bronchodilators (LABAs / LAMAs) on Patients Health Related Quality of Life in COPD Patients

Boehringer Ingelheim·observational·Posted Sep 9, 2013·Updated Jul 27, 2018

In Brief

An observational study evaluating Tiotropium 2x2.5µg tiotropium (equivalent to 2x3.154µg tiotropium bromide monohydrate) Respimat® inhaler and cartridge Solution for inhalation, Indacterol 300 µg, and 2 other interventions for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 645 participants across 1 site.

Detailed Summary

The objective of the study is to observe the effect of adherence to once-daily administered long-acting bronchodilators (long-acting ß2-agonists \[LABAs\] / long-acting muscarinic antagonists \[LAMAs\]) on patients health related quality of life (HR-QoL) and to assess the relation between symptoms improvement and adherence to Chronic Obstructive Pulmonary Disease (COPD) maintenance therapy

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 9, 2013
Enrollment StartNov 6, 2011
Primary CompletionOct 22, 2016
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 12.8 years ago

Interventions

Tiotropium 2x2.5µg tiotropium (equivalent to 2x3.154µg tiotropium bromide monohydrate) Respimat® inhaler and cartridge Solution for inhalationdrug

Respimat® inhaler and cartridge Solution for inhalation

Indacterol 300 µgdrug

inhalation powder

Tiotropium 18µg (equivalent to 22.5µg tiotropium bromide monohydrate) HandiHaler® device Inhalation powder, hard capsuledrug

HandiHaler® device Inhalation powder, hard capsule

Indacterol 150 µgdrug

inhalation powder